Acadia Healthcare Company EBIT

The latest EBIT for ACHC is $-850M as of June 2026. That compares with $320M in the prior-year period — down 363.8% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Acadia Healthcare Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACHC's EBIT moved from $320M to $-850M — a 363.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acadia Healthcare Company's operating scale or balance-sheet position.

Against Healthcare companies, ACHC currently prints $-850M for EBIT, while the sector average sits near $22B. That is roughly 103.8% below the sector mean. Large gaps often invite a closer look at Acadia Healthcare Company's growth, margins, and balance sheet.

A EBIT figure of $-850M for ACHC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting ACHC's EBIT ($-850M), review year-over-year change from $320M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.